Search Results - Christopher F. Spurney

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Can Coronary Artery Involvement in Kawasaki Disease be Predicted? by Sunil J. Ghelani, Christopher F. Spurney, Neha S. Kwatra

    Published in Diagnostics (2013-03-01)
    Get full text
    Article


  2. 2

    Glucocorticoid-treated mice are an inappropriate positive control for long-term preclinical studies in the mdx mouse. by Arpana Sali, Alfredo D Guerron, Heather Gordish-Dressman, Christopher F Spurney, Micaela Iantorno, Eric P Hoffman, Kanneboyina Nagaraju

    Published in PLoS ONE (2012-01-01)
    Get full text
    Article


  3. 3

    The proton pump inhibitor lansoprazole improves the skeletal phenotype in dystrophin deficient mdx mice. by Arpana Sali, Gina M Many, Heather Gordish-Dressman, Jack H van der Meulen, Aditi Phadke, Christopher F Spurney, Avital Cnaan, Eric P Hoffman, Kanneboyina Nagaraju

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  4. 4

    Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel by Christopher F Spurney, Lawrence Charnas, Linda Cripe, Kan Hor, Nicholas King, Kathi Kinnett, Elizabeth M McNally, John-Michael Sauer, Lee Sweeney, Chet Villa, Larry W Markham

    Published in Open Heart (2021-02-01)
    Get full text
    Article


  5. 5

    Rate of Change in Cardiac Magnetic Resonance Imaging Measures Is Associated With Death in Duchenne Muscular Dystrophy by Joseph R. Starnes, Meng Xu, Kristen George‐Durrett, Kimberly Crum, Frank J. Raucci, Christopher F. Spurney, Kan N. Hor, Linda H. Cripe, Nazia Husain, Sujatha Buddhe, Katheryn Gambetta, Jaclyn Tamaroff, James C. Slaughter, Larry W. Markham, Jonathan H. Soslow

    Get full text
    Article


Search Tools: